March Today, just 1 in 5,000 experimental compounds proves safe and effective enough to reach patients. For new drugs, the road to hospitals and clinics is steep and long. Researchers screen countless promising compounds, but they choose only a few to begin clinical trials. Of those selected, roughly 9 out of 10 will fail. For that […]
Before lupus research, Dr. Joan Merrill tried her hand at stage and screen.
New England Journal of Medicine publishes lupus drug trial paper authored by OMRF expert
Clinical trial results illustrate incremental advances in lupus research.
OMRF’s lupus cohort marks 20 years
Tens of thousands of patient samples have contributed to worldwide research.
Life Changer: Oklahoma’s lupus cohort marks 20 years
Oklahoma’s lupus cohort marks 20 years.
OMRF honors scientists, board member at spring meeting
OMRF awarded scientific prizes to four scientists and honored a board member on Tuesday at its spring board meeting.